A detailed history of Gsa Capital Partners LLP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 3,668 shares of ITCI stock, worth $313,503. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,668
Previous 3,353 9.39%
Holding current value
$313,503
Previous $232,000 8.19%
% of portfolio
0.02%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$64.76 - $79.84 $20,399 - $25,149
315 Added 9.39%
3,668 $251,000
Q1 2024

May 03, 2024

BUY
$64.37 - $75.65 $215,832 - $253,654
3,353 New
3,353 $232,000
Q3 2023

Nov 15, 2023

BUY
$52.09 - $64.1 $71,415 - $87,881
1,371 Added 20.31%
8,122 $423,000
Q2 2023

Aug 14, 2023

BUY
$54.67 - $66.44 $369,077 - $448,536
6,751 New
6,751 $427,000
Q4 2022

Feb 13, 2023

BUY
$44.07 - $54.45 $241,944 - $298,930
5,490 New
5,490 $291,000
Q2 2021

Aug 05, 2021

SELL
$29.3 - $44.5 $270,028 - $410,112
-9,216 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$30.8 - $39.51 $283,852 - $364,124
9,216 New
9,216 $313,000
Q2 2020

Aug 11, 2020

SELL
$14.35 - $26.64 $201,517 - $374,105
-14,043 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$12.31 - $33.12 $172,869 - $465,104
14,043 New
14,043 $216,000
Q4 2019

Feb 12, 2020

SELL
$7.26 - $38.49 $303,634 - $1.61 Million
-41,823 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$7.47 - $14.03 $312,417 - $586,776
41,823 New
41,823 $312,000
Q1 2019

May 15, 2019

SELL
$10.9 - $14.09 $135,694 - $175,406
-12,449 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$10.36 - $20.96 $128,971 - $260,931
12,449 New
12,449 $142,000
Q3 2018

Nov 13, 2018

SELL
$17.77 - $22.9 $863,515 - $1.11 Million
-48,594 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$17.33 - $23.4 $76,251 - $102,960
4,400 Added 9.96%
48,594 $859,000
Q1 2018

May 11, 2018

SELL
$15.16 - $25.49 $1.01 Million - $1.71 Million
-66,906 Reduced 60.22%
44,194 $930,000
Q4 2017

Feb 14, 2018

BUY
$14.27 - $16.79 $1.59 Million - $1.87 Million
111,100
111,100 $1.61 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.07B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.